HomeSGX-LISTED COMPANIESLMIR Trust's Q2 2025 Financial Performance and Outlook

LMIR Trust’s Q2 2025 Financial Performance and Outlook

Published on

spot_img

LMIR Trust has unveiled its 2Q 2025 results, highlighting a period of ongoing operational recovery and an increase in gross revenue. The Trust continues to prioritise prudent capital management and strategic asset enhancements amidst persistent macroeconomic headwinds.

• The portfolio witnessed improved occupancy rates through active tenant engagement and successful lease renewals
• The Trust’s financial strategy focuses on managing debt obligations and bolstering financial flexibility in an uncertain economic climate
• The Indonesian retail sector faces subdued consumer sentiment and currency volatility, even with government measures to boost domestic consumption

Latest articles

Top Glove Q3 FY2026 Earnings Rise Despite Fluctuating Material Costs

Resilient Growth and Strategic Agility Top Glove Corporation has reported a remarkable 138% year-on-year surge...

AstraZeneca invests US$20M to curb Malaysia chronic disease burden

AstraZeneca is scaling up early screening and clinical research efforts in Malaysia as the...

AstraZeneca expands diagnostics and AI to tackle late-stage cancer deaths

AstraZeneca is sharpening its long-term AstraZeneca cancer strategy with a combination of heavy research...

AstraZeneca deploys AI to cut drug timelines by 30% and boost survival

AstraZeneca is stepping up its investment in AI drug discovery to shorten treatment timelines...

More like this

Top Glove Q3 FY2026 Earnings Rise Despite Fluctuating Material Costs

Resilient Growth and Strategic Agility Top Glove Corporation has reported a remarkable 138% year-on-year surge...

AstraZeneca invests US$20M to curb Malaysia chronic disease burden

AstraZeneca is scaling up early screening and clinical research efforts in Malaysia as the...

AstraZeneca expands diagnostics and AI to tackle late-stage cancer deaths

AstraZeneca is sharpening its long-term AstraZeneca cancer strategy with a combination of heavy research...